In November 2019, the Agency approved revisions to the labeling for insulin pens recommending that the products be dispensed in the original sealed carton. As insulin pens often have similar appearances and are not labeled for dispensing as individual units, the carton helps both healthcare professionals and patients distinguish between the products, which are available in a variety of formulations and dosages.
